Seekyo reinforces scientific advisory board with two new members
NovAliX acquires Sanofi site in Strasbourg and creates Guy Ourisson Research Campus
Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis
Genoscience Pharma licences GNS561, its PPT-1 inhibitor, to GENFIT in cholangiocarcinoma indication in US/Canada and Europe
Phase 2 clinical program in cholangiocarcinoma expected to start first half of 2022
Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of Biofit
The Belgian start-up is developing an effective and reproducible phage therapy approach that offers a personalized solution to the major issue of AntiMicrobial Resistance (AMR)
Advent France Biotechnology becomes AdBio partners
New name reflects venture capital firm’s international expansion as group of entrepreneur-investors adding value in biotech
Name change follows launch of second fund in September 2021 with first close at €86M aimed at building tomorrow’s most promising biotech start-ups
Genoskin launches MANTIS, a spatial biology imaging platform dedicated to skin immunology
MANTIS (Multiplex ANnotated Tissue Imaging System) was developed at Infinity (Inserm U1291, France) by Dr. Nicolas Gaudenzio and his team; Dr. Gaudenzio was recently appointed as Genoskin’s Chief Scientific Officer (CSO)
Genoskin licensed intellectual property from Inserm to develop MANTIS as a spatial biology platform dedicated to skin immunology and to characterizing drug effects on human skin
PDC*line Pharma raises €17.5 million ($20.3M) in Series B2 financing round
